Duloxetine Update

October 30, 2006 at 4:26 pm | In Prescribing Extra - Drugs | Print Print | No Comments

Duloxetine (Cymbalta®) is an antidepressant that has been the subject of several previous postings. Some of this information is now in need of an update.

To clarify the current situation:

  • The Scottish Medicines Consortium have restricted use of duloxetine in Scotland
  • Lancashire Care Trust have restrictions in place on duloxetine
  • The Summary of Product Characteristics recommends that patients (and carers) are made aware of the need to monitor for suicidal ideation/behaviour and that there is “close supervision of high-risk patients“
  • The MHRA publication Current Problems in Pharmacovigilance recommends “careful and frequent patient monitoring during treatment is recommended, particularly for high risk groups.“
  • [Update] Leeds NHS Health Community (PCT, Acute and Care Trusts) have recommended restricted use of duloxetine

Action: The existing advice remains unchanged at this time; duloxetine should not be used as an antidepressant in a Primary Care Setting.

Copyright ©2006 Prescribing Advice for GPs

No Comments yet »

RSS feed for comments on this post. TrackBack URI

Leave a comment

XHTML: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS Feed for New Entries.
Akismet has protected Prescribing Advice for GPs from 5,902 spam comments.